NANO-X IMAGING LTD announces a registered direct offering of 3,826,530 ordinary shares for approximately $15 million. The offering is expected to close on November 25, 2025, and will be used for working capital and general corporate purposes. This move aims to strengthen the company’s balance sheet and support key growth initiatives, like advancing technologies and expanding market presence. Titan Partners Group is the sole placement agent for the offering. The offering is made under an effective shelf registration statement on Form F-3. Nanox is focused on affordable medical imaging technologies to enhance preventive healthcare and early detection worldwide.

Read more at GlobeNewswire: Nanox Announces $15 Million Registered Direct Offering of